June 22 (Reuters) - The U.S. Food and Drug Administration said on Monday it is launching a series of measures to speed ‌up drug research, from early-stage investigational studies to late-stage trials, ...
Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Well, it's funny because ...
Boehringer Ingelheim spent the weekend pointing to survodutide's “targeted” weight loss, but the latest data couldn’t shake off concerns about the obesity drug’s tolerability. The deep dive into ...
What Is Decnupaz, and Why Does It Matter? Decnupaz (pivekimab sunirine-pvzy) is a targeted cancer medicine called an antibody-drug conjugate (ADC). It is now approved for adults with a rare, ...
Take-Two Interactive, the parent company of Rockstar Games, has ordered the GTA 5 modding platform Rage: MP to cease operations. The developers of the platform relayed the news via a forum post on ...
May 7 (Reuters) - Entrada Therapeutics' (TRDA.O), opens new tab drug for children with Duchenne muscular dystrophy fell well short of analyst expectations in an early-to-mid stage trial, sending its ...
The National Drug Control Strategy is prepared biennially by the Office of National Drug Control Policy. This document provides a strategic roadmap for the Administration to continue dismantling the ...
The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of April 2026. The chart below provides highlights of key monograph updates ...
GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. Watch out for the Benzies family in Schedule 1, as the rival cartel ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The dispute centers on ...
Eli Lilly (LLY) fell in premarket trading after Bloomberg reported that weekly prescriptions for the company’s weight loss therapies, Foundayo and Zepbound, trailed those for Novo Nordisk’s (NVO) ...